Cartesian Therapeutics Inc (RNAC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 212,610 | 76,911 | 106,438 | 114,057 | 138,685 |
| Marketable Securities | N/A | N/A | 28,164 | 13,998 | 0 |
| Receivables | 872 | 8,851 | 9,758 | 9,914 | 7,224 |
| TOTAL | $216,626 | $90,729 | $148,138 | $144,443 | $151,343 |
| Non-Current Assets | |||||
| PPE Net | 9,912 | 2,113 | 2,794 | 2,142 | 1,395 |
| Investments And Advances | 2,000 | 2,000 | 2,000 | 2,000 | 0 |
| Intangibles | 48,163 | 48,163 | 0 | 0 | 0 |
| Other Non-Current Assets | 158,322 | 162,045 | 12,954 | 11,298 | 12,697 |
| TOTAL | $218,397 | $214,321 | $17,748 | $15,440 | $14,092 |
| Total Assets | $435,023 | $305,050 | $165,886 | $159,883 | $165,435 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 8,476 | 5,961 | 0 |
| Accounts payable and accrued liabilities | 288 | 3,150 | 316 | 224 | 443 |
| Accrued Expenses | 12,076 | 15,572 | 14,084 | 10,533 | 8,146 |
| Other current liabilities | 7,761 | 45,010 | N/A | N/A | N/A |
| TOTAL | $22,976 | $68,209 | $25,077 | $72,251 | $81,547 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 17,786 | 19,673 | 24,793 |
| Deferred Revenues | 0 | 2,311 | 593 | 53,883 | 72,050 |
| Other Non-Current Liabilities | 402,708 | 357,080 | 29,195 | 34,021 | 38,355 |
| TOTAL | $418,849 | $376,471 | $46,981 | $65,111 | $101,894 |
| Total Liabilities | $441,825 | $444,680 | $72,058 | $137,362 | $183,441 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 25,907 | 5,393 | 5,106 | 4,139 | 3,742 |
| Common Shares | 3 | 1 | 15 | 12 | 11 |
| Retained earnings | -692,071 | -614,647 | -394,937 | -430,316 | -404,629 |
| Other shareholders' equity | -4,621 | -4,600 | -4,558 | -4,566 | -4,563 |
| TOTAL | $-6,802 | $-139,630 | $93,828 | $22,521 | $-18,006 |
| Total Liabilities And Equity | $435,023 | $305,050 | $165,886 | $159,883 | $165,435 |